{"id":725020,"date":"2023-01-23T10:03:10","date_gmt":"2023-01-23T15:03:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/"},"modified":"2023-01-23T10:03:10","modified_gmt":"2023-01-23T15:03:10","slug":"summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/","title":{"rendered":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PHILADELPHIA, Jan.  23, 2023  (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (\u201cSummit\u201d) on behalf of the Company\u2019s investors.<\/p>\n<p align=\"left\">The investigation seeks to determine whether Summit issued false and misleading statements and\/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company\u2019s shareholders.<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <em>Summit shareholders <\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em>are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 \u2013 0750, or by email (<\/em><br \/>\n        <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CtFpDL68Hd7Vf8rYLjNLg25CAbH4xGXaeDU7XdqYZfJsaTwPtHib1220OXUFU7nvORD_hn2OkRt79rFCg7ZZGV3X0Efx8I9VPRb5dQP0HC0=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>abell@kaskelalaw.com<\/em><br \/>\n          <\/strong><br \/>\n        <\/a><br \/>\n        <strong><br \/>\n          <em>) or online at <\/em><br \/>\n        <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pT_hqI44TfesYgdguGovcvcx7Je4SmKv8gHWgn87I_jLtL3zQTb7a7i7YU_yEyHs9lkXHqlLXfRvq-q1-wSenQjB9EGiOTXC1pADwp2hOxdyvJVVvUNdzNhUdQ0GCnSjDySc1X_MuX_gqR3PdwGvOcJSgCUWoNFWN8yBs9Tn-sc=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <em>https:\/\/kaskelalaw.com\/cases\/summit-therapeutics\/<\/em><br \/>\n          <\/strong><br \/>\n        <\/a><br \/>\n        <strong><br \/>\n          <em>, for additional information about this investigation and their legal rights and options. <\/em><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation. For additional information about Kaskela Law LLC please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WcQ--ZPoLFKpB7QYU0bFGMN0sErsK_OUkOsRTJp1FUFRUzqhRRIj3FbnZBa-e3cIct5F7JFWPh-bJ8OpAnY1CCG7iOdQeDZS6gwz0MWw1eQ=\" rel=\"nofollow noopener\" target=\"_blank\">www.kaskelalaw.com<\/a>. This notice may constitute attorney advertising in certain jurisdictions.<\/p>\n<p align=\"left\">\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<p align=\"left\">D. Seamus Kaskela, Esq.<br \/>Adrienne Bell, Esq.<br \/><strong>KASKELA LAW LLC<\/strong><br \/>18 Campus Blvd., Suite 100<br \/>Newtown Square, PA 19073<br \/>(484) 229 \u2013 0750<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WcQ--ZPoLFKpB7QYU0bFGN2oQPNVPNvOT1iF1ODGAjflZauVPeXclbZuEi5g2mSPuMeGNIam7Iy08-aKcJFpBxl75FbNS4BcJVaDOKZ1Fw0=\" rel=\"nofollow noopener\" target=\"_blank\">www.kaskelalaw.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGI0NzgyNDctMTZiYS00YTBjLTllMWMtNzhjM2NlODZiNWRhLTExMTE1MDY=\/tiny\/Kaskela-Law.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (\u201cSummit\u201d) on behalf of the Company\u2019s investors. The investigation seeks to determine whether Summit issued false and misleading statements and\/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company\u2019s shareholders. Summit shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 \u2013 0750, or by email ( abell@kaskelalaw.com ) or online at https:\/\/kaskelalaw.com\/cases\/summit-therapeutics\/ , for additional information about this investigation and their legal rights and options. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation. For additional information about &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-725020","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (\u201cSummit\u201d) on behalf of the Company\u2019s investors. The investigation seeks to determine whether Summit issued false and misleading statements and\/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company\u2019s shareholders. Summit shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 \u2013 0750, or by email ( abell@kaskelalaw.com ) or online at https:\/\/kaskelalaw.com\/cases\/summit-therapeutics\/ , for additional information about this investigation and their legal rights and options. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation. For additional information about &hellip; Continue reading &quot;SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-23T15:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm\",\"datePublished\":\"2023-01-23T15:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/\"},\"wordCount\":179,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/\",\"name\":\"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\",\"datePublished\":\"2023-01-23T15:03:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk","og_description":"PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (\u201cSummit\u201d) on behalf of the Company\u2019s investors. The investigation seeks to determine whether Summit issued false and misleading statements and\/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company\u2019s shareholders. Summit shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 \u2013 0750, or by email ( abell@kaskelalaw.com ) or online at https:\/\/kaskelalaw.com\/cases\/summit-therapeutics\/ , for additional information about this investigation and their legal rights and options. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation. For additional information about &hellip; Continue reading \"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-23T15:03:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm","datePublished":"2023-01-23T15:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/"},"wordCount":179,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/","name":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=","datePublished":"2023-01-23T15:03:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNDExOCM1MzY3ODQ3IzIwOTk5MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/summit-investor-alert-kaskela-law-llc-announces-stockholder-investigation-of-summit-therapeutics-inc-smmt-and-encourages-smmt-investors-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=725020"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/725020\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=725020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=725020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=725020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}